{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T13:00:40Z","timestamp":1782997240929,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Brandenburg CAMPUS GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background and aim<\/jats:title>\n            <jats:p>Spondyloarthritides (SpA) are common entities of the inflammatory rheumatic type. There are still 3 relevant problems in everyday clinical practice: early disease detection, cardiovascular risk assessment, and less so, disease activity measurement. Metabolomics allows the quantification of a large number of small-molecule substances from biological samples.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The following databases were searched for references: PubMed, Web of Science, Cochrane Library, Scopus. The period lasted from 1973 until 2024.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Finally, 14 analyses were identified. Most studies have evaluated patients with established disease. Some studies were able to un-mask metabolomic characteristics of certain forms of SpA. Approaches that utilize an integrative view of several metabolites in combination with general patient characteristics appear to be quite promising. Such approaches are suitable, for example, for assessing activity in psoriatic arthritis (PsA) or evaluating cardiovascular risk in individuals with psoriatic disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Metabolomics are helpful in identifying new diagnostic and predictive parameters in SpA, so far mainly in PsA. An almost consistent limitation of the studies to date is the inclusion of patients with already manifest disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41927-025-00546-3","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T03:27:57Z","timestamp":1753241277000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolomics in spondylarthritis"],"prefix":"10.1186","volume":"9","author":[{"given":"Susann","family":"Patschan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Remus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Claus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike","family":"Hoffmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Patschan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"issue":"1","key":"546_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, Akkoc N, Brandt J, Chou CT, et al. The assessment of SpondyloArthritis International society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2011, Jan;70(1):25\u201331.","journal-title":"Ann Rheum Dis"},{"issue":"4 Suppl 73","key":"546_CR2","first-page":"S132","volume":"30","author":"J Braun","year":"2012","unstructured":"Braun J. Axial spondyloarthritis: Thoughts about nomenclature and treatment targets. Clin Exp Rheumatol. 2012;30(4 Suppl 73):S132\u2013135.","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"546_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11926-020-00934-3","volume":"22","author":"N Akkoc","year":"2020","unstructured":"Akkoc N, Khan MA. Is axial spondyloarthritis more common than rheumatoid arthritis? Curr Rheumatol Rep. 2020, Sep;22(9):54.","journal-title":"Curr Rheumatol Rep"},{"issue":"10","key":"546_CR4","first-page":"591","volume":"18","author":"A Finckh","year":"2022","unstructured":"Finckh A, Gilbert B, Hodkinson B, Bae SC, Thomas R, Deane KD, et al. Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol. 2022, Oct;18(10):591\u2013602.","journal-title":"Nat Rev Rheumatol"},{"issue":"Suppl4","key":"546_CR5","doi-asserted-by":"publisher","first-page":"iv6","DOI":"10.1093\/rheumatology\/keaa250","volume":"59","author":"D Poddubnyy","year":"2020","unstructured":"Poddubnyy D. Classification vs diagnostic criteria: The challenge of diagnosing axial spondyloarthritis. Rheumatol Oxf Engl. 2020, Oct 1;59(Suppl4):iv6\u201317.","journal-title":"Rheumatol Oxf Engl"},{"issue":"6","key":"546_CR6","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.ekir.2020.03.012","volume":"5","author":"N Champtiaux","year":"2020","unstructured":"Champtiaux N, Liot\u00e9 F, El Karoui K, Vigneau C, Miceli C, Cornec-Le Gall E, et al. Spondyloarthritis-associated IgA nephropathy. Kidney Int Rep. 2020, Jun;5(6):813\u201320.","journal-title":"Kidney Int Rep"},{"issue":"1","key":"546_CR7","doi-asserted-by":"publisher","first-page":"e001136","DOI":"10.1136\/rmdopen-2019-001136","volume":"6","author":"P Carron","year":"2020","unstructured":"Carron P, De Craemer AS, Van den Bosch F. Peripheral spondyloarthritis: A neglected entity-state of the art. RMD Open. 2020, May;6(1):e001136.","journal-title":"RMD Open"},{"issue":"2","key":"546_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/14397595.2020.1830512","volume":"31","author":"H Kameda","year":"2021","unstructured":"Kameda H, Kobayashi S, Tamura N, Kadono Y, Tada K, Yamamura M, et al. Non-radiographic axial spondyloarthritis. Mod Rheumatol. 2021, Mar;31(2):277\u201382.","journal-title":"Mod Rheumatol"},{"issue":"10","key":"546_CR9","first-page":"790","volume":"102","author":"R Agca","year":"2016","unstructured":"Agca R, Heslinga SC, van Halm VP, Nurmohamed MT. Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders. Heart Br Card Soc. 2016, May, 15;102(10):790\u201395.","journal-title":"Heart Br Card Soc"},{"issue":"5","key":"546_CR10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41584-021-00593-3","volume":"17","author":"F Atzeni","year":"2021","unstructured":"Atzeni F, Rodr\u00edguez-Carrio J, Popa CD, Nurmohamed MT, Sz\u0171cs G, Szekanecz Z. Cardiovascular effects of approved drugs for rheumatoid arthritis. Nat Rev Rheumatol. 2021, May;17(5):270\u201390.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"546_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","volume":"76","author":"R Agca","year":"2017","unstructured":"Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJL, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann Rheum Dis. 2017, Jan;76(1):17\u201328.","journal-title":"Ann Rheum Dis"},{"key":"546_CR12","doi-asserted-by":"publisher","first-page":"965709","DOI":"10.3389\/fmicb.2022.965709","volume":"13","author":"T Huang","year":"2022","unstructured":"Huang T, Pu Y, Wang X, Li Y, Yang H, Luo Y, et al. Metabolomic analysis in spondyloarthritis: A systematic review. Front Microbiol. 2022;13:965709.","journal-title":"Front Microbiol"},{"issue":"1","key":"546_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/mas.20108","volume":"26","author":"K Dettmer","year":"2007","unstructured":"Dettmer K, Aronov PA, Hammock BD. Mass spectrometry-based metabolomics. Mass Spectrom Rev. 2007, Feb;26(1):51\u201378.","journal-title":"Mass Spectrom Rev"},{"key":"546_CR14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/978-981-33-6064-8_19","volume":"1310","author":"SJ Kim","year":"2021","unstructured":"Kim SJ, Song HE, Lee HY, Yoo HJ. Mass spectrometry-based Metabolomics in translational research. Adv Exp Med Biol. 2021;1310:509\u201331.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"546_CR15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s13075-016-1139-2","volume":"18","author":"W Wang","year":"2016","unstructured":"Wang W, Jin YG, Zhang J, Chen C, Yu JZ, Li J, et al. Plasma, urine and ligament tissue metabolite profiling reveals potential biomarkers of ankylosing spondylitis using NMR-based metabolic profiles. Arthritis Res Ther. 2016, Dec;18(1):244.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"546_CR16","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s10238-022-00958-2","volume":"23","author":"H Li","year":"2023","unstructured":"Li H, Wang L, Zhu J, Xiao J, Yang H, Hai H, et al. Diagnostic serum biomarkers associated with ankylosing spondylitis. Clin Exp Med. 2023, Sep;23(5):1729\u201339.","journal-title":"Clin Exp Med"},{"issue":"acs.jproteome","key":"546_CR17","doi-asserted-by":"publisher","first-page":"8b00439","DOI":"10.1021\/acs.jproteome.8b00439","volume":"30","author":"D Dubey","year":"2018","unstructured":"Dubey D, Kumar S, Chaurasia S, Guleria A, Ahmed S, Singh R, et al. NMR-Based serum Metabolomics revealed distinctive metabolic patterns in reactive arthritis compared with rheumatoid arthritis. J Proteome Res. 2018, Oct;30(acs.jproteome):8b00439.","journal-title":"J Proteome Res"},{"issue":"6","key":"546_CR18","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1093\/rheumatology\/keaa746","volume":"60","author":"JR Parida","year":"2021","unstructured":"Parida JR, Kumar S, Ahmed S, Chaurasia S, Mukherjee R, Singh R, et al. Reactive arthritis and undifferentiated peripheral spondyloarthritis share human leucocyte antigen B27 subtypes and serum and synovial fluid cytokine profiles. Rheumatol Oxf Engl. 2021, Jun, 18;60(6):3004\u201311.","journal-title":"Rheumatol Oxf Engl"},{"issue":"4","key":"546_CR19","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/1756-185X.13490","volume":"22","author":"S Ahmed","year":"2019","unstructured":"Ahmed S, Dubey D, Chowdhury A, Chaurasia S, Guleria A, Kumar S, et al. Nuclear magnetic resonance-based metabolomics reveals similar metabolomics profiles in undifferentiated peripheral spondyloarthritis and reactive arthritis. Int J Rheum Dis. 2019, Apr;22(4):725\u201333.","journal-title":"Int J Rheum Dis"},{"issue":"7","key":"546_CR20","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1093\/rheumatology\/kez493","volume":"59","author":"H Muhammed","year":"2020","unstructured":"Muhammed H, Kumar D, Dubey D, Kumar S, Chaurasia S, Guleria A, et al. Metabolomics analysis revealed significantly higher synovial Phe\/Tyr ratio in reactive arthritis and undifferentiated spondyloarthropathy. Rheumatol Oxf Engl. 2020, Jul, 1;59(7):1587\u201390.","journal-title":"Rheumatol Oxf Engl"},{"issue":"4","key":"546_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/annrheumdis-2019-216374","volume":"79","author":"M Souto-Carneiro","year":"2020","unstructured":"Souto-Carneiro M, T\u00f3th L, Behnisch R, Urbach K, Klika KD, Carvalho RA, et al. Differences in the serum metabolome and lipidome identify potential biomarkers for seronegative rheumatoid arthritis versus psoriatic arthritis. Ann Rheum Dis. 2020, Apr;79(4):499\u2013506.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"546_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0049-0172(73)90035-8","volume":"3","author":"JM Moll","year":"1973","unstructured":"Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum. 1973;3(1):55\u201378.","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"546_CR23","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.1021\/acs.jproteome.1c00620","volume":"20","author":"D Dubey","year":"2021","unstructured":"Dubey D, Kumar S, Rawat A, Guleria A, Kumari R, Ahmed S, et al. NMR-Based metabolomics revealed the underlying inflammatory pathology in reactive arthritis synovial joints. J Proteome Res. 2021, Nov, 5;20(11):5088\u2013102.","journal-title":"J Proteome Res"},{"issue":"7","key":"546_CR24","first-page":"59","volume":"17","author":"N Looby","year":"2021","unstructured":"Looby N, Roszkowska A, Reyes-Garc\u00e9s N, Yu M, B\u0105czek T, Kulasingam V, et al. Serum metabolic fingerprinting of psoriasis and psoriatic arthritis patients using solid-phase microextraction-liquid chromatography-high-resolution mass spectrometry. Metabolomics Off J Metabolomic Soc. 2021, Jun, 16;17(7):59.","journal-title":"Metabolomics Off J Metabolomic Soc"},{"issue":"2","key":"546_CR25","doi-asserted-by":"publisher","first-page":"300060525131394","DOI":"10.1177\/03000605251313949","volume":"53","author":"C Remus","year":"2025","unstructured":"Remus C, Hoffmeister M, Strathmeyer S, Heelemann S, Claus I, Dammermann W, et al. Dysregulation of amino acid and lipid metabolism in patients with spondyloarthritis. J Int Med Res. 2025, Feb;53(2):3000605251313949.","journal-title":"J Int Med Res"},{"issue":"2","key":"546_CR26","doi-asserted-by":"publisher","first-page":"M111.013904","DOI":"10.1074\/mcp.M111.013904","volume":"11","author":"R Fischer","year":"2012","unstructured":"Fischer R, Trudgian DC, Wright C, Thomas G, Bradbury LA, Brown MA, et al. Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis. Mol Cell Proteomics MCP. 2012, Feb;11(2):M111.013904.","journal-title":"Mol Cell Proteomics MCP"},{"issue":"2","key":"546_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/mrc.5083","volume":"59","author":"L Gupta","year":"2021","unstructured":"Gupta L, Guleria A, Rawat A, Kumar D, Aggarwal A. NMR-based clinical metabolomics revealed distinctive serum metabolic profiles in patients with spondyloarthritis. Magn Reson Chem MRC. 2021, Feb;59(2):85\u201398.","journal-title":"Magn Reson Chem MRC"},{"issue":"1","key":"546_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/art.42288","volume":"75","author":"A Paine","year":"2023","unstructured":"Paine A, Brookes PS, Bhattacharya S, Li D, De La Luz Garcia-Hernandez M, Tausk F, et al. Dysregulation of bile acids, lipids, and nucleotides in psoriatic arthritis revealed by unbiased profiling of serum metabolites. Arthritis Rheumatol Hoboken NJ. 2023, Jan;75(1):53\u201363.","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"1","key":"546_CR29","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jaad.2018.06.027","volume":"80","author":"F Alinaghi","year":"2019","unstructured":"Alinaghi F, Calov M, Kristensen LE, Gladman DD, Coates LC, Jullien D, et al. Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol. 2019, Jan;80(1):251\u201365.e19.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"546_CR30","first-page":"17","volume":"20","author":"J Koussiouris","year":"2024","unstructured":"Koussiouris J, Looby N, Kotlyar M, Kulasingam V, Jurisica I, Chandran V. Classifying patients with psoriatic arthritis according to their disease activity status using serum metabolites and machine learning. Metabolomics Off J Metabolomic Soc. 2024, Jan, 24;20(1):17.","journal-title":"Metabolomics Off J Metabolomic Soc"},{"issue":"11","key":"546_CR31","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1136\/annrheumdis-2021-220168","volume":"80","author":"K Colaco","year":"2021","unstructured":"Colaco K, Lee KA, Akhtari S, Winer R, Welsh P, Sattar N, et al. Targeted metabolomic profiling and prediction of cardiovascular events: A prospective study of patients with psoriatic arthritis and psoriasis. Ann Rheum Dis. 2021, Nov;80(11):1429\u201335.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"546_CR32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.14740\/jocmr4913","volume":"15","author":"D Patschan","year":"2023","unstructured":"Patschan D, Patschan S, Matyukhin I, Hoffmeister M, Lauxmann M, Ritter O, et al. Metabolomics in acute kidney injury: The experimental perspective. J Clin Med Res. 2023, Jun;15(6):283\u201391.","journal-title":"J Clin Med Res"},{"issue":"12","key":"546_CR33","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.3390\/jcm12124083","volume":"12","author":"D Patschan","year":"2023","unstructured":"Patschan D, Patschan S, Matyukhin I, Ritter O, Dammermann W. Metabolomics in acute kidney injury: The clinical perspective. J Clin Med. 2023, Jun, 16;12(12):4083.","journal-title":"J Clin Med"},{"issue":"21","key":"546_CR34","doi-asserted-by":"publisher","first-page":"e2300218","DOI":"10.1002\/mnfr.202300218","volume":"67","author":"Y Hui","year":"2023","unstructured":"Hui Y, Zhao J, Yu Z, Wang Y, Qin Y, Zhang Y, et al. The role of tryptophan metabolism in the occurrence and progression of acute and chronic kidney diseases. Mol Nutr Food Res. 2023, Nov;67(21):e2300218.","journal-title":"Mol Nutr Food Res"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-025-00546-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-025-00546-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-025-00546-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T18:20:43Z","timestamp":1757269243000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcrheumatol.biomedcentral.com\/articles\/10.1186\/s41927-025-00546-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["546"],"URL":"https:\/\/doi.org\/10.1186\/s41927-025-00546-3","relation":{},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study did not require ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval andconsent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"92"}}